185 related articles for article (PubMed ID: 32127832)
1. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
Zhang P; Liu Y; Ren Y; Bai J; Zhang G; Cui Y
Afr Health Sci; 2019 Sep; 19(3):2591-2599. PubMed ID: 32127832
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis.
Konwar M; Bose D; Jaiswal SK; Maurya MK; Ravi R
Int J Clin Pract; 2022; 2022():1201977. PubMed ID: 35936066
[TBL] [Abstract][Full Text] [Related]
3. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS.
O'Neil PM; Garvey WT; Gonzalez-Campoy JM; Mora P; Ortiz RV; Guerrero G; Claudius B; Pi-Sunyer X;
Endocr Pract; 2016 Nov; 22(11):1277-1287. PubMed ID: 27482610
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.
Manigault KR; Thurston MM
Consult Pharm; 2016 Dec; 31(12):685-697. PubMed ID: 28074747
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
[TBL] [Abstract][Full Text] [Related]
6. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.
Gou H; Zhai Y; Guo J
Eur J Pediatr; 2023 Nov; 182(11):5095-5108. PubMed ID: 37672063
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.
Armstrong MJ; Houlihan DD; Rowe IA; Clausen WH; Elbrønd B; Gough SC; Tomlinson JW; Newsome PN
Aliment Pharmacol Ther; 2013 Jan; 37(2):234-42. PubMed ID: 23163663
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide for the treatment of type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials.
Du Q; Wang YJ; Yang S; Zhao YY; Han P
Adv Ther; 2014 Nov; 31(11):1182-95. PubMed ID: 25388240
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide: A New Option for the Treatment of Obesity.
Nuffer WA; Trujillo JM
Pharmacotherapy; 2015 Oct; 35(10):926-34. PubMed ID: 26497479
[TBL] [Abstract][Full Text] [Related]
11. Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials.
Su N; Li Y; Xu T; Li L; Kwong JS; Du H; Ren K; Li Q; Li J; Sun X; Li S; Tian H
Int J Cardiol; 2016 Sep; 219():293-300. PubMed ID: 27343423
[TBL] [Abstract][Full Text] [Related]
12. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H; Khemani D; Eckert D; O'Neill J; Kadouh H; Grothe K; Clark MM; Burton DD; Vella A; Acosta A; Zinsmeister AR; Camilleri M
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):890-899. PubMed ID: 28958851
[TBL] [Abstract][Full Text] [Related]
13. Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhang F; Tong Y; Su N; Li Y; Tang L; Huang L; Tong N
J Diabetes; 2015 May; 7(3):329-39. PubMed ID: 25043423
[TBL] [Abstract][Full Text] [Related]
14. Exposure-response analyses of liraglutide 3.0 mg for weight management.
Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
[TBL] [Abstract][Full Text] [Related]
15. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
16. liraglutide (SAXENDA⁰) and obesit. Still no satisfactory weight loss drugs.
Prescrire Int; 2016 Jan; 25(167):5-8. PubMed ID: 26942248
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials.
Lin Q; Xue Y; Zou H; Ruan Z; Ung COL; Hu H
Expert Rev Clin Pharmacol; 2022 Dec; 15(12):1461-1469. PubMed ID: 36180402
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Dimitrios P; Michael D; Vasilios K; Konstantinos S; Konstantinos I; Ioanna Z; Konstantinos P; Spyridon B; Asterios K
Curr Diabetes Rev; 2020; 16(4):313-326. PubMed ID: 31203802
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide's Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis.
Alsanea S; Alkofide H; Almadi B; Almohammed O; Alwhaibi A; Alrabiah Z; Kalagi N
Endocr Pract; 2024 May; ():. PubMed ID: 38782201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
